Setting the Course for Comprehensive Care Navigation in Oncology Evolent experts describe the key pieces of a scalable, comprehensive care navigation program in an article in Evidence-Based Oncology. Read Article
From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care Chief Medical Officer Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to Evolent. Read Article
The “dystopian” state of primary care Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care. Read Article
It's Cancer Prevention Month. Here are 11 ways to reduce your risk. Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more. Read External Article
Prophylactic Mastectomy for Patients With High-Risk Gene Mutations Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations. Watch Video
Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more. Read External Article
Medicare Drug Price Negotiations and Anticipated Ripple Effects Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies. Read External Article
Genetic testing in cancer care: Considerations for a condition-based approach Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care. Read External Article
Evolent facilitates response to cancer drug shortages Evolent takes a multifaceted approach to help providers navigate shortages of cisplatin, carboplatin and other anti-cancer drugs. Read Article
Reducing Cancer Therapy’s Toll on the Heart Evolent is leveraging our expertise in two key specialties to reduce cardiovascular damage related to cancer drugs. Read Article
